Kamada - Public Comps and Valuation Multiples

Kamada Overview

About Kamada

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Founded

1990

HQ

Employees

374

Website

kamada.com

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
Vaccines & Immunotherapies
BioTech

Financials

LTM Revenue $589M

LTM EBITDA $141M

EV

$343M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Kamada Financials

As of November 2025, Kamada reported last 12-month revenue of $589M and EBITDA of $141M.

In the same period, Kamada generated $254M in LTM gross profit and $67.8M in net income.

See Kamada valuation multiples based on analyst estimates

Kamada P&L

In the most recent fiscal year, Kamada reported revenue of $49.5M and EBITDA of $8.5M.

Kamada expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Kamada valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$589M	XXX	$49.5M	XXX	XXX	XXX
Gross Profit	$254M	XXX	$21.5M	XXX	XXX	XXX
Gross Margin	43%	XXX	43%	XXX	XXX	XXX
EBITDA	$141M	XXX	$8.5M	XXX	XXX	XXX
EBITDA Margin	24%	XXX	17%	XXX	XXX	XXX
EBIT	$91.2M	XXX	$6.2M	XXX	XXX	XXX
EBIT Margin	15%	XXX	12%	XXX	XXX	XXX
Net Profit	$67.8M	XXX	$4.4M	XXX	XXX	XXX
Net Margin	11%	XXX	9%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Kamada including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $589M. EBITDA for the last twelve months was $141M. In the most recent fiscal year, Kamada achieved $49.5M in revenue and $8.5M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$589M	Analyst estimates available to subscribers	$49.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$254M	Analyst estimates available to subscribers	$21.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	43.1% gross margin	Analyst estimates available to subscribers	43.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$141M	Analyst estimates available to subscribers	$8.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	23.9% EBITDA margin	Analyst estimates available to subscribers	17.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$91.2M	Analyst estimates available to subscribers	$6.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	15.5% EBIT margin	Analyst estimates available to subscribers	12.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$67.8M	Analyst estimates available to subscribers	$4.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	11.5% net profit margin	Analyst estimates available to subscribers	9.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Kamada

This financial data table provides comprehensive performance metrics for Kamada, a company based in Israel. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Kamada generated $589M in revenue over the last twelve months.
The company achieved $141M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $254M.
Net income over the last twelve months reached $67.8M.

Fiscal Year Performance

In the most recent fiscal year, Kamada reported $49.5M in total revenue.
Fiscal year EBITDA was $8.5M.
The company maintained a gross profit margin of 43.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 17.3%.
Net profit margin reached 9.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Kamada. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Kamada Stock Performance

Kamada has current market cap of ILS 1.3B (or $403M), and EV of ILS 1.1B (or $343M).

Market Cap Evolution

Kamada Stock Data

As of December 3, 2025, Kamada's stock price is ILS 23 (or $7).

See Kamada trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$343M	$403M	XXX	XXX	XXX	XXX	$0.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Kamada Valuation Multiples

Kamada's trades at 6.9x EV/Revenue multiple, and 40.1x EV/EBITDA.

See valuation multiples for Kamada and 15K+ public comps

Kamada Financial Valuation Multiples

As of December 3, 2025, Kamada has market cap of $403M and EV of $343M.

Equity research analysts estimate Kamada's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Kamada has a P/E ratio of 19.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$403M	XXX	$403M	XXX	XXX	XXX
EV (current)	$343M	XXX	$343M	XXX	XXX	XXX
EV/Revenue	1.9x	XXX	6.9x	XXX	XXX	XXX
EV/EBITDA	7.9x	XXX	40.1x	XXX	XXX	XXX
EV/EBIT	12.2x	XXX	55.6x	XXX	XXX	XXX
EV/Gross Profit	4.4x	XXX	n/a	XXX	XXX	XXX
P/E	19.4x	XXX	90.7x	XXX	XXX	XXX
EV/FCF	10.2x	XXX	30.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kamada Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Kamada Margins & Growth Rates

Kamada's last 12 month revenue growth is 9%

Kamada's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $41K for the same period.

Kamada's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kamada's rule of X is 47% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kamada and other 15K+ public comps

Kamada Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	101%	XXX	XXX	XXX
EBITDA Margin	24%	XXX	17%	XXX	XXX	XXX
EBITDA Growth	3%	XXX	152%	XXX	XXX	XXX
Rule of 40	25%	XXX	26%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	47%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$41K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	9%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	31%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial